Multiplex Assay Kit for Prostaglandin F2 Alpha (PGF2a) ,etc. by FLIA (Flow Luminescence Immunoassay)

PGF2A; PGF2-A; PG-F2a

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Prostaglandin F2 Alpha (PGF2a) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Prostaglandin F2 Alpha (PGF2a) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of Prostaglandin F2 Alpha (PGF2a) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Prostaglandin F2 Alpha (PGF2a) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 90-104 97
EDTA plasma(n=5) 86-103 89
heparin plasma(n=5) 79-95 88

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Prostaglandin F2 Alpha (PGF2a) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Prostaglandin F2 Alpha (PGF2a) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Prostaglandin F2 Alpha (PGF2a) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 90-98% 92-101% 96-105% 98-105%
EDTA plasma(n=5) 80-92% 90-102% 93-101% 87-102%
heparin plasma(n=5) 93-105% 85-101% 90-98% 87-94%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:PGF2a) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 50μL standard or sample to each well,
    add 10μL magnetic beads,and 50μL Detection Reagent A,incubate 60min at 37°C on shaker;
3. Wash plate on magnetic frame for three times;
4. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
5. Wash plate on magnetic frame for three times;
6. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Pharmacognosy Reaserach Vitex negundo?inhibits cyclooxygenase-2 inflammatory cytokine-mediated inflammation on carrageenan-induced rat hind paw edema PubMed: PMC3424839
J Breath Res Effects of different ventilation strategies on exhaled nitric oxide in geriatric abdominal surgery PubMed: 25719610
Gynecol Endocrinol Application of atosiban in frozen-thawed cycle patients with different times of embryo transfers Pubmed:27147474
Fertility and Sterility Administration of atosiban in patients with endometriosis undergoing frozen–thawed embryo transfer: a prospective, randomized study pubmed:27143518
Biochemical and Biophysical Research Communications The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion Pubmed: 30558792
Diabetes & Metabolic Syndrome: Clinical Research & Reviews Association of fasting glucagon-like peptide-1 with oxidative stress and subclinical atherosclerosis in type 2 diabetes
Journal of Diabetes Research Supplementation with Korean Red Ginseng Improves Current Perception Threshold in Korean Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo … Pubmed: 32025522
LIFE SCIENCES Intravitreal conbercept improves outcome of proliferative diabetic retinopathy through inhibiting inflammation and oxidative stress Pubmed: 33227274
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE The microvesicle/CD36 complex triggers a prothrombotic phenotype in patients with non‐valvular atrial fibrillation Pubmed: 32510852
archives of gerontology and geriatrics The effect of Korean Red Ginseng on sarcopenia biomarkers in type 2 diabetes patients Pubmed: 32470863
Catalog No. Related products for research use of Pan-species (General) Organism species Applications (RESEARCH USE ONLY!)
PAA749Ge01 Polyclonal Antibody to Prostaglandin F2 Alpha (PGF2a) WB; IHC; ICC; IP.
MAA749Ge22 Monoclonal Antibody to Prostaglandin F2 Alpha (PGF2a) ELISA, CLIA. / IHC-Fr, ICC, IP (predicted).
MAA749Ge23 Monoclonal Antibody to Prostaglandin F2 Alpha (PGF2a) WB; IHC; ICC; IP.
MAA749Ge24 Monoclonal Antibody to Prostaglandin F2 Alpha (PGF2a) ELISA, CLIA. / IHC-Fr, ICC, IP (predicted).
MAA749Ge21 Monoclonal Antibody to Prostaglandin F2 Alpha (PGF2a) ELISA, CLIA. / IHC-Fr, ICC, IP (predicted).
CEA749Ge ELISA Kit for Prostaglandin F2 Alpha (PGF2a) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA749Ge Multiplex Assay Kit for Prostaglandin F2 Alpha (PGF2a) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.